In 1980, an American scientist conducted a gene technology experiment outside of the country where he was working, to circumnavigate the USA regulations at that time. He transferred rDNA into the bone marrow cells of two patients with hereditary blood disorders.
The experiment did not have approval from his USA university, and it was in direct opposition to National Institute of Health gene therapy guidelines.
There was further concern that he’d done limited animal trials on mice that were unsuccessful.
Learn more here.
